Pembrolizumab And Lenvatinib In Leptomeningeal Metastases

Clinical trial NCT04729348 · TERMINATED

Trial details

NCT number: NCT04729348
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Solid Tumor, Adult Leptomeningeal Metastasis

Start date: 2021-03-08
Primary completion: 2024-01-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.